Cargando…
Seven‐year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence
AIMS: Bulking agents are a minimally invasive treatment option for women with stress urinary incontinence (SUI) or stress‐predominant mixed urinary incontinence (MUI). The aim of this study was to evaluate long‐term efficacy and safety following treatment with Bulkamid as a primary procedure for SUI...
Autores principales: | Brosche, Torsten, Kuhn, Annette, Lobodasch, Kurt, Sokol, Eric R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839440/ https://www.ncbi.nlm.nih.gov/pubmed/33410544 http://dx.doi.org/10.1002/nau.24589 |
Ejemplares similares
-
An open multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and mixed urinary incontinence
por: Lose, Gunnar, et al.
Publicado: (2010) -
Durability, safety and efficacy of polyacrylamide hydrogel (Bulkamid(®)) in the management of stress and mixed urinary incontinence: three year follow up outcomes
por: Pai, Aakash, et al.
Publicado: (2015) -
Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and stress-predominant mixed incontinence
por: Toozs-Hobson, Philip, et al.
Publicado: (2012) -
Quality of life and sexual function after TVT surgery versus Bulkamid injection for primary stress urinary incontinence: 1 year results from a randomized clinical trial
por: Itkonen Freitas, Anna-Maija, et al.
Publicado: (2020) -
An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation
por: Futyma, Konrad, et al.
Publicado: (2015)